Director Kimberly J. Tzoumakas resigns from Coherus board effective Dec 31, 2024

Coherus Oncology, Inc.

Kimberly J. Tzoumakas resigned from Coherus BioSciences Board, effective December 31, 2024.
Resignation was not due to any disagreement with the Company's operations, policies, or practices.
No replacement director has been announced as of the filing date.
The Company thanked Ms. Tzoumakas for her contributions during her tenure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.